Robert W Lentz

Pancreatic Ductal Adenocarcinoma Cells Regulate NLRP3 Activation to Generate a Tolerogenic Microenvironment

T. Pitts, W. Messersmith, S. Atif, 2023, Cancer research communications.

Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tumor organoid library (PTOL)

T. Pitts, J. Arcaroli, W. Messersmith, 2024, PloS one.

Prolonged Response to Dabrafenib/Trametinib in Grade 3 Metastatic Pancreatic Neuroendocrine Tumor (NET G3) with BRAF V600E Mutation

B. Ueberroth, Robert W Lentz, C. H. Lieu, 2024, Journal of gastrointestinal cancer.

A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer

T. Pitts, S. Bagby, Tyler Friedrich, 2024, Clinical cancer research : an official journal of the American Association for Cancer Research.

HER2-Positive Metastatic Colorectal Cancer.

W. Messersmith, Robert W Lentz, Hannah R Robinson, 2024, Current treatment options in oncology.